Cochrane Abstracts
Histamine type 2 receptor antagonists as adjuvant treatment for resected colorectal cancer: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Histamine Type 2 Receptor Antagonists as Adjuvant Treatment for Resected Colorectal Cancer: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432988/all/Screening_and_case_finding_instruments_for_depression_Edited__no_change_to_conclusions_. Accessed 26 April 2024.
Histamine type 2 receptor antagonists as adjuvant treatment for resected colorectal cancer: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432988/all/Screening_and_case_finding_instruments_for_depression_Edited__no_change_to_conclusions_. Accessed April 26, 2024.
Histamine type 2 receptor antagonists as adjuvant treatment for resected colorectal cancer: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/432988/all/Screening_and_case_finding_instruments_for_depression_Edited__no_change_to_conclusions_
Histamine Type 2 Receptor Antagonists as Adjuvant Treatment for Resected Colorectal Cancer: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2024 April 26]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432988/all/Screening_and_case_finding_instruments_for_depression_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Histamine type 2 receptor antagonists as adjuvant treatment for resected colorectal cancer: Cochrane systematic review
ID - 432988
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432988/all/Screening_and_case_finding_instruments_for_depression_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -
